Approval for the tula® system. This device is intended to create a myringotomy and insert a tympanostomy tube using the tula tube delivery system in pediatric (aged 6 months and older) and adult patients indicated to receive tympanostomy tubes. The tula system is used to deliver a tympanostomy tube under local anesthesia induced using the tula iontophoresis system and tymbion™, a combination of an amide local anesthetic and an alpha- and beta-adrenergic agonist. Tymbion™, a combination of an amide local anesthetic and an alpha- and beta-adrenergic agonist, is indicated for the induction of local anesthesia of the tympanic membrane via iontophoresis using the tula® iontophoresis system in pediatric (aged 6 months and older) and adult patients undergoing tympanostomy tube placement using the tula tube delivery systemdrug indications and usage: tymbion™, a combination of an amide local anesthetic and an alpha- and beta-adrenergic agonist, is indicated for the induction of local anesthesia of the tympanic membrane via iontophoresis using the tula® iontophoresis system in pediatric (aged 6 months and older) and adult patients undergoing tympanostomy tube placement using the tula tube delivery system.
Device | Tula® System |
Classification Name | Tympanostomy Tube Delivery Product With Drug |
Generic Name | Tympanostomy Tube Delivery Product With Drug |
Applicant | Tusker Medical, Inc. |
Date Received | 2019-05-31 |
Decision Date | 2019-11-25 |
Notice Date | 2019-11-27 |
PMA | P190016 |
Supplement | S |
Product Code | QJA |
Docket Number | 19M-5605 |
Advisory Committee | Ear Nose & Throat |
Expedited Review | No |
Combination Product | Yes |
Applicant Address | Tusker Medical, Inc. 155 Jefferson Drive, Suite 200 menlo Park, CA 94025 |
Summary: | Summary of Safety and Effectiveness |
Labeling: | Labeling Labeling Part 2 |
Approval Order: | Approval Order |
Supplement Number | Date | Supplement Type |
---|---|---|
P190016 | Original Filing | |
S006 | 2022-09-22 | Real-time Process |
S005 | 2022-08-24 | 30-day Notice |
S004 | ||
S003 | 2021-08-09 | 30-day Notice |
S002 | 2020-10-29 | Real-time Process |
S001 | 2020-04-09 | 30-day Notice |